FLT3 and acute myeloid leukemia: As Notch signaling is generally silenced in AML at baseline,19 we hypothesized that Notch activation after FLT3-TKI treatment may be a cellular feedback mechanism to compensate for drug-induced cytotoxicity, and Notch inhibition may enhance the effects of FLT3-TKIs.